Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 4

Clinical and laboratory efficacy of repetitive triamcinolone injections in carpal tunnel syndrome

Pages
640–645
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is recommended to use a maximum of 3 injections at intervals of 2-3 months.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim:Carpal tunnel syndrome (CTS) is the most common compressive neuropathy affecting the upper extremity.
📊
Key Findings & Data:It is recommended to use a maximum of 3 injections at intervals of 2-3 months.
💡
Conclusion & Impact:Consequently, 40 mg of triamcinolone, applied approximately 3 cm distal to the carpal tunnel, is as effective as the more frequently applied techniques.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim:Carpal tunnel syndrome (CTS) is the most common compressive neuropathy affecting the upper extremity. There are many surgical and non-surgical treatment options and it is not clear which approach is more effective. Corticosteroid injections are known to be effective on both CTS symptoms and electrophysiological parameters. Many different techniques are used for injection. It is recommended to use a maximum of 3 injections at intervals of 2-3 months. In our study, we aimed to examine the clinical and electrophysiological efficacy of triamcinolone injection performed in the cases with a rarely used technique.Material and Methods: This is a retrospective study.Patients who were diagnosed with mild to moderate CTS between December 2012 and June 2018 treated with 40 mg triamcinolone injection were evaluated. Ages of patients were between 18 to 65 years. The changes in the electrophysiological parameters, clinical and examination findings, and visual analog scale (VAS) of 121 patients were examined before and after the injections.Results: Clinical and examination findings were consistent with previous studies. The second injection was applied to 43.9% and the third injection to 16.4% of the cases. After the third injection, mild to moderate CTS was detected in 6.9% of the cases. The statistically significant changes were observed in the clinical, examination findings and VAS values of the cases before and after the injection. Besides, a significant statistical difference was determined in all parameters of the sensory conductions and in the distal latency of the motor conduction, before and after the injection.Conclusion: It was determined that 40 mg of triamcinolone caused a significant change in VAS values, and the clinical and examination findings of CTS. There were no complications associated with injection. Consequently, 40 mg of triamcinolone, applied approximately 3 cm distal to the carpal tunnel, is as effective as the more frequently applied techniques.

🔖

Cite This Article

SONKAYA, A. R., SİMSEK, F., CEYLAN, M. (2022). Clinical and laboratory efficacy of repetitive triamcinolone injections in carpal tunnel syndrome. Annals of Medical Research, Cilt: 26 - Sayı: 4, 640–645. https://ajindex.com/articles/447404

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Atroshi, I, Gummesson, C, Johnsson, R. Prevalence of carpal tunnel syndrome in a general population. JAMA. 1999;282:153-8
  2. Fernández-de-Las-Peñas C, Cleland J, Palacios-Ceña M, et al. The Effectiveness of Manual Therapy Versus Surgery on Self-reported Function, Cervical Range of Motion, and Pinch Grip Force in Carpal Tunnel Syndrome: A Randomized Clinical Trial. J Orthop Sports Phys Ther 2017;47:151-61
  3. Burke FD, Ellis J, McKenna H, et al. Primary care management of carpal tunnel syndrome. Postgrad Med J. 2003;79:433-7
  4. Kim HJ, Park SH. Median nerve injuries caused by carpal tunnel injections. Korean J Pain. 2014; 27:112-7
  5. Cranford CS, Ho JY, Kalainov DM, Carpal tunnel syndrome. J Am Acad Orthop Surg 2007;15:537-48
  6. Lee JH, An JH, Lee SH, et al. Effectiveness of steroid injection in treating patients with moderate and severe degree of carpal tunnel syndrome measured by clinical and electrodiagnostic assessment. Clin J Pain 2009;25:111-5
  7. Ozturk K1, Esenyel CZ, Sonmez M, et al. Comparison of carpal tunnel injection techniques: a cadaver study. Scand J Plast Reconstr Surg Hand Surg 2008;42:300-4
  8. Racasan O, Dubert TH. The safest location for steroid injection in the treatment of carpal tunnel syndrome. J Hand Surg Br 2005;30:412-4
  9. Visser LH, Ngo Q, Groeneweg SJ, et al. Long term effect of local corticosteroid injection for carpal tunnel syndrome: a relation with electrodiagnostic severity. Clin Neurophysiol 2012;123:838-41
  10. Chen LC, Ho CW, Sun CH, et al. Ultrasound-Guided Pulsed Radiofrequency for Carpal Tunnel Syndrome: A Single-Blinded Randomized Controlled Study. PLoS One 2015;10: e0129918
  11. Jenkins PJ, Duckworth AD, Watts AC, et al. Corticosteroid injection for carpal tunnel syndrome: a 5-year survivorship analysis. Hand (N Y) 2012;7:151-6
  12. Graham B, Peljovich AE, Afra R, et al. The American academy of orthopaedic surgeons evidence-based clinical practice guideline on: management of carpal tunnel syndrome. J Bone Joint Surg Am 2016;98:1750-4
  13. Huisstede BM, Fridén J, Coert JH, et al. Carpal tunnel syndrome: hand surgeons, hand therapists, and physical medicine and rehabilitation physicians agree on a multidisciplinary treatment guideline-results from the European HANDGUIDE Study. Arch Phys Med Rehabil 2014;95:2253-63
  14. Habib, GS, Badarny, S, Rawashdeh, H. A novel approach of local corticosteroid injection for the treatment of carpal tunnel syndrome. Clin Rheumatol 2006;25:338-40
  15. Ata AM, Şahin Onat Ş, Kar